Peyronie's disease: Contemporary evaluation and management
- PMID: 32253786
- DOI: 10.1111/iju.14230
Peyronie's disease: Contemporary evaluation and management
Abstract
Peyronie's disease is a common yet poorly understood condition characterized by penile pain, curvature, sexual dysfunction and psychological bother. Peyronie's disease represents a penile wound healing disorder, and is thought to arise from exuberant scarring in response to penile trauma in genetically predisposed men. In the absence of active treatment, the majority of men experience stable or worsening symptoms, with few reporting spontaneous resolution in penile curvature or other deformity. In contrast, penile pain improves or resolves in the majority of men. Treatment options vary based on symptom severity and stability. Several oral therapies are commonly prescribed, although to date there are no strong data to support any oral agents as monotherapy for Peyronie's disease. Other options including penile traction therapy and intralesional injections result in modest improvements for many patients, particularly when used early after symptom onset. Penile straightening through approaches, such as penile plication and plaque incision or partial excision and grafting, represent the most rapid and reliable approach to correct penile curvature once the symptoms have stabilized. Side-effects vary based on the type of surgery carried out, and include penile shortening, sensation changes and erectile dysfunction in the minority of men. In patients with drug refractory erectile dysfunction and Peyronie's disease, placement of a penile prosthesis will address both issues, and is associated with high levels of patient satisfaction. The current review provides a practical approach to the modern evaluation and management of patients presenting with Peyronie's disease.
Keywords: Xiaflex; collagenase; grafting; penile curvature; plication.
© 2020 The Japanese Urological Association.
Comment in
-
Editorial Comment to Peyronie's disease: Contemporary evaluation and management.Int J Urol. 2020 Jun;27(6):516-517. doi: 10.1111/iju.14253. Epub 2020 Apr 20. Int J Urol. 2020. PMID: 32314443 No abstract available.
Similar articles
-
Management of Peyronie's disease--a review.World J Urol. 2001 Aug;19(4):244-50. World J Urol. 2001. PMID: 11550782 Review.
-
Review of Management Options for Patients With Atypical Peyronie's Disease.Sex Med Rev. 2017 Apr;5(2):211-221. doi: 10.1016/j.sxmr.2016.07.004. Epub 2016 Aug 17. Sex Med Rev. 2017. PMID: 27544298 Review.
-
Surgical Planning and Strategies for Peyronie's Disease.Sex Med Rev. 2021 Jul;9(3):478-487. doi: 10.1016/j.sxmr.2020.07.008. Epub 2020 Oct 3. Sex Med Rev. 2021. PMID: 33023863 Review.
-
Modern treatment strategies for penile prosthetics in Peyronie's disease: a contemporary clinical review.Asian J Androl. 2020 Jan-Feb;22(1):51-59. doi: 10.4103/aja.aja_81_19. Asian J Androl. 2020. PMID: 31424027 Free PMC article. Review.
-
Outcomes of a Novel Penile Traction Device in Men with Peyronie's Disease: A Randomized, Single-Blind, Controlled Trial.J Urol. 2019 Sep;202(3):599-610. doi: 10.1097/JU.0000000000000245. Epub 2019 Aug 8. J Urol. 2019. PMID: 30916626 Clinical Trial.
Cited by
-
The efficacy and safety of intralesional injection of collagenase Clostridium histolyticum for Peyronie's disease: A meta-analysis of published prospective studies.Front Pharmacol. 2022 Oct 5;13:973394. doi: 10.3389/fphar.2022.973394. eCollection 2022. Front Pharmacol. 2022. PMID: 36278151 Free PMC article. Review.
-
Penile fibrosis-still scarring urologists today: a narrative review.Transl Androl Urol. 2024 Jan 31;13(1):127-138. doi: 10.21037/tau-23-206. Epub 2024 Jan 23. Transl Androl Urol. 2024. PMID: 38404545 Free PMC article. Review.
-
Penile surgery for patients with Peyronie's disease initially treated with collagenase clostridium histolyticum or surgery: a claims database analysis.Int J Impot Res. 2023 Mar;35(2):147-151. doi: 10.1038/s41443-021-00522-8. Epub 2022 Jan 10. Int J Impot Res. 2023. PMID: 35013566 Free PMC article.
-
Long-term outcomes of extracorporeal shock wave therapy for acute Peyronie's disease: a 10-year retrospective analysis.Int J Impot Res. 2024 Apr;36(2):135-139. doi: 10.1038/s41443-023-00673-w. Epub 2023 Feb 14. Int J Impot Res. 2024. PMID: 36788352
-
Clinical Presentation of Peyronie's Disease: A Retrospective Study of 564 Cases.Diagnostics (Basel). 2024 May 29;14(11):1125. doi: 10.3390/diagnostics14111125. Diagnostics (Basel). 2024. PMID: 38893650 Free PMC article.
References
-
- de la Peyronie F. Sur quelques obstacles qui s' opposent a l'ejaculation naturelle de la semence. Mem. Acad. R. Chir. 1743; 1: 425-34.
-
- Akkus E. Historical review of Peyronie’s disease. In: Levine LA (ed.). Peyronie’s Disease. Humana Press, Totowa, 2007; 1-8.
-
- Mohede DCJ, de Jong IJ, van Driel MF. Medical treatments of Peyronie's disease: past, present, and future. Urology 2019; 125: 1-5.
-
- Musitelli S, Bossi M, Jallous H. A brief historical survey of “Peyronie’s disease.” J. Sex. Med. 2008; 5: 1737-46.
-
- De Rose AF, Mantica G, Bocca B, Szpytko A, Van der Merwe A, Terrone C. Supporting the role of penile trauma and micro-trauma in the etiology of Peyronie’s disease. Prospective observational study using the electronic microscope to examine two types of plaques. Aging Male 2019; https://doi.org/10.1080/13685538.2019.1586870.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical